Warren G. Magnuson Clinical Center (CC)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001194
This protocol is designed to investigate the use of novel techniques in MRI that may not yet be commercially available. Specifically, the protocol enables patients to take advantage of new pulse sequence software, coil design or post processing capabilities not otherwise available. The informed consent explains MRI in lay terms, describes the use of contrast agents and lists contraindications to MRI.
Looking for future studies?
Notify MeAll sexes
Observational
Bethesda, Maryland, 20892, United States
NMR imaging promises to provide useful and unique diagnostic information in a variety of diseases. In an attempt to evaluate its role, we plan to study a wide range of diseases during the initial year of imaging. Exposure to magnetic fields and radiofrequency energies of this magnitude have demonstrated no deleterious effects clinically or in the laboratory. The only restrictions will be those imposed by ferromagnetic objects within the patient which would increase the risk of placing them in a strong magnetic field.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Any patient undergoing MRI for research or clinical purposes who is participating in a currently active NIH protocol.
No patients with pacemakers, cochlear implants, implanted pumps, shrapnel, metal in the globe of the eye, cerebral aneurysm clips or other contraindication to MRI.
National Institutes of Health Clinical Center (CC)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04257253
Atrophy, Back Pain
Montreal, Quebec, Canada
View Trial DetailsNCT05823857
Atrophy, Back Pain
Montreal, Quebec, Canada
View Trial DetailsNCT06744192
Acetabular Labrum Tear, Diagnostic Imaging
Beijing, Beijing Municipality, China
View Trial DetailsNCT05984082
Artificial Intelligence, Diagnostic Imaging
Philadelphia, Pennsylvania, United States
View Trial Details